Celularity (CELU) Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101
Go back to Celularity (CELU) Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101| (NASDAQ: CELU) | Delayed: 0.74 +0.01 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.74 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 4,176 | |||||
